Standardization of immunoassays for measurement of myoglobin in serum. Phase 1: Evaluation of candidate secondary reference materials

被引:17
|
作者
Panteghini, M [1 ]
Linsinger, T
Wu, AHB
Dati, F
Apple, FS
Christenson, RH
Mair, J
Schimmel, H
机构
[1] Azienda Osped Spedali Civili, Lab Anal Chim Clin 1, I-25125 Brescia, Italy
[2] Inst Ref Mat & Measurements, Geel, Belgium
[3] Hartford Hosp, Dept Pathol & Lab Med, Hartford, CT USA
[4] IVD Consulting, Marburg, Germany
[5] Hennepin Cty Med Ctr, Dept Lab Med & Pathol, Minneapolis, MN USA
[6] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[7] Univ Maryland, Med Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[8] Univ Innsbruck, Sch Med, Div Cardiol, Dept Internal Med, Innsbruck, Austria
关键词
myoglobin; standardization; commutability; reference materials;
D O I
10.1016/j.cccn.2003.10.030
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Myoglobin is a low-molecular weight protein present in the cytosol of striated muscles. Its concentrations in serum can be measured by immunoassays and are used as an early indicator of myocardial necrosis. Since variability among commercial myoglobin assays exists, standardization of myoglobin assays is needed. Methods: An international collaborative study was organized with the involvement of seven companies using 12 different automated platforms for measuring myoglobin. Five candidate secondary, i.e., matrixed, reference materials were assayed in relation to linearity, imprecision, recovery rate and commutability to demonstrate a possible identity between the materials and the usual routine serum samples. Results: One Iyophilized candidate material (human heart myoglobin in human serum) was selected as the most suitable secondary reference material, based on the criteria examined. Used as a calibrator a posteriori, the bias between the various myoglobin assays for a frozen human serum pool was reduced from 32% to 13%. Conclusion: This study provides the basis for the selection of an internationally recognized secondary reference material. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 35 条
  • [31] Evaluation of portable X-ray fluorescence (pXRF) in exploration and mining: Phase 1, control reference materials
    Hall, Gwendy E. M.
    Bonham-Carter, Graeme F.
    Buchar, Angelina
    GEOCHEMISTRY-EXPLORATION ENVIRONMENT ANALYSIS, 2014, 14 (02) : 99 - 123
  • [32] Evaluation and clinical application of a bracketing calibration-based isotope dilution liquid chromatography-tandem mass spectrometry candidate reference measurement procedure for serum theophylline
    Du, Yuanyuan
    Yan, Qiaofang
    Zhan, Min
    Zhang, Qiaoxuan
    Huang, Di
    Zhang, Pengwei
    Yan, Jun
    Wang, Jianbing
    Huang, Xianzhang
    Han, Liqiao
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2024, 416 (22) : 4897 - 4906
  • [33] Measurement of serum 17-hydroxyprogesterone using isotope dilution liquid chromatography-tandem mass spectrometry candidate reference method and evaluation of the performance for three routine methods
    Long, Qichen
    Zhang, Tianjiao
    Yan, Ying
    Zhao, Haijian
    Zhou, Weiyan
    Zeng, Jie
    Li, Shuijun
    Zhang, Jiangtao
    Zeng, Qingzhang
    Zhao, Beibei
    Zhang, Chuanbao
    Chen, Wenxiang
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (03) : 523 - 532
  • [34] Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure
    Farre-Segura, Jordi
    Le Goff, Caroline
    Lukas, Pierre
    Cobraiville, Gael
    Fillet, Marianne
    Servais, Anne-Catherine
    Delanaye, Pierre
    Cavalier, Etienne
    CLINICAL CHEMISTRY, 2022, 68 (11) : 1399 - 1409
  • [35] Evaluation of proficiency survey results for complement components 3 and 4, transferrin, haptoglobin, alpha-1-antitrypsin, prealbumin, and C-reactive protein following the introduction of a new international reference preparation for proteins in human serum.
    Ledue, TB
    Cherry, CD
    Ritchie, RF
    Johnson, AM
    CLINICAL CHEMISTRY, 1999, 45 (06) : A52 - A52